Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-25 @ 4:17 AM
NCT ID:
NCT07151820
Eligibility Criteria:
Inclusion criteria:
Patients who met all of the following criteria were considered for inclusion:
* Had at least two diagnoses for CML- International Classification of Disease, 10th revision, Clinical Modification (ICD-10-CM) code: C92.1x
* Aged 18 years or older at the time of first CML diagnosis
* Received a 1G or 2G TKI after the first CML diagnosis
* Had continuous health plan enrollment (pharmacy and medical benefits) for at least 6 months before the index date (baseline) and 6 months after the index date
Exclusion criteria:
Patients who met any of the following criteria were excluded:
* Patients had 2 or more diagnoses of gastrointestinal stromal tumor (\[GIST\], ICD-10: C49.Ax) or chronic myelomonocytic leukemia (\[CMML\], ICD-10: C93.1x) at any time
* Patients had a hematopoietic stem cell transplantation (HSCT) during the baseline period
* Patients had CML-related chemotherapy treatment for accelerated phase (AP)/blast crisis (BC) during the baseline period
* Patients had medical claims associated with a clinical trial during the baseline period up to the end of the observation period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07151820
Study Brief:
Protocol Section:
NCT07151820